We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
122 hedge funds and large institutions have $1.13B invested in Atara Biotherapeutics in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 60 increasing their positions, 20 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
200% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 20
111% more capital invested
Capital invested by funds: $535M → $1.13B (+$596M)
101% more call options, than puts
Call options by funds: $1.5M | Put options by funds: $746K
52% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 21
10% more funds holding
Funds holding: 111 → 122 (+11)
0.04% more ownership
Funds ownership: 4.29% → 4.34% (+0.04%)
Holders
122
Holders Change
+11
Holders Change %
+9.91%
% of All Funds
2.5%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
32
Increased
60
Reduced
20
Closed
21
Calls
$1.5M
Puts
$746K
Net Calls
+$756K
Net Calls Change
+$338K
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$52.9M |
| 2 |
Goldman Sachs
New York
|
+$29.2M |
| 3 |
BG
Baupost Group
Boston,
Massachusetts
|
+$16.3M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
+$15.7M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$15.7M |
